Intravenous epidermal growth factor/urogastrone increases small-intestinal cell proliferation in congenital microvillous atrophy.
Walker-Smith
J A
JA
Phillips
A D
AD
Walford
N
N
Gregory
H
H
Fitzgerald
J D
JD
MacCullagh
K
K
Wright
N A
NA
D001284:Atrophy; D003967:Diarrhea / Q000151:congenital / Q000188:drug therapy / Q000473:pathology; D004815:Epidermal Growth Factor / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007223:Infant; D007275:Injections, Intravenous; D007413:Intestinal Mucosa / Q000473:pathology*; D008871:Microvilli / Q000473:pathology; D010446:Peptide Fragments / Q000008:administration & dosage / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D013577:Syndrome
D010446:Peptide Fragments; D011994:Recombinant Proteins; D004815:Epidermal Growth Factor; C035693:epidermal growth factor (1-45)